• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

印度尼西亚草药和肉桂及姜黄成分对蛋白酪氨酸磷酸酶 1B 的抑制活性。

Protein tyrosine phosphatase 1B inhibitory activity of Indonesian herbal medicines and constituents of Cinnamomum burmannii and Zingiber aromaticum.

机构信息

Institute of Natural Medicine, University of Toyama, Toyama, Japan.

出版信息

J Nat Med. 2013 Apr;67(2):264-70. doi: 10.1007/s11418-012-0674-7. Epub 2012 May 30.

DOI:10.1007/s11418-012-0674-7
PMID:22645080
Abstract

We screened water and methanol extracts of 28 Indonesian medicinal plants for their protein tyrosine phosphatase 1B (PTP1B) inhibitory activities. Nine water extracts, i.e., Alstonia scholaris leaf, Blumea balsamifera, Cinnamomum burmannii, Cymbopogon nardus, Melaleuca leucadendra, Phyllanthus niruri, Piper nigrum, Syzygium aromaticum, and Sy. polyanthum, exhibited ≥70 % inhibition at 25 μg/mL, whereas 11 methanol extracts, i.e., Als. scholaris, Andrographis paniculata, B. balsamifera, Ci. burmannii, Curcuma heyneana, Glycyrrhiza glabra, M. leucadendra, Punica granatum, Rheum palmatum, Sy. polyanthum, and Z. aromaticum, exhibited ≥70 % inhibition at 25 μg/mL. Water extracts of B. balsamifera (IC50, 2.26 μg/mL) and M. leucadendra (IC50, 2.05 μg/mL), and methanol extracts of Ci. burmannii (IC50, 2.47 μg/mL), Pu. granatum (IC50, 2.40 μg/mL), and Sy. polyanthum (IC50, 1.03 μg/mL) exhibited strong inhibitory activity, which was comparable with that of the positive control, RK-682 (IC50, 2.05 μg/mL). The PTP1B inhibitory activity of the constituents of Ci. burmannii and Z. aromaticum was then evaluated. 5'-Hydroxy-5-hydroxymethyl-4″,5″-methylenedioxy-1,2,3,4-dibenzo-1,3,5-cycloheptatriene (2; IC50, 29.7 μM) and trans-cinnamaldehyde (5; IC50, 57.6 μM) were the active constituents of Ci. burmannii, while humulatrien-5-ol-8-one (21; IC50, 27.7 μM), kaempferol-3,4'-di-O-methyl ether (32; IC50, 17.5 μM), and (S)-6-gingerol (33; IC50, 28.1 μM) were those of Z. aromaticum. These results suggest that these medicinal plants may contribute to the treatment and/or prevention of type II diabetes and/or obesity through PTP1B inhibition.

摘要

我们筛选了 28 种印度尼西亚药用植物的水提物和甲醇提取物,以研究它们对蛋白酪氨酸磷酸酶 1B(PTP1B)的抑制活性。9 种水提取物,即醉茄叶、白花丹、肉桂、香茅草、千层塔、鸡骨草、黑胡椒、八角茴香和多花山姜,在 25μg/mL 时表现出≥70%的抑制活性,而 11 种甲醇提取物,即醉茄、穿心莲、白花丹、肉桂、莪术、甘草、千层塔、石榴、大黄、多花山姜和八角茴香,在 25μg/mL 时表现出≥70%的抑制活性。水提物中,白花丹(IC50,2.26μg/mL)和千层塔(IC50,2.05μg/mL),以及甲醇提取物中,肉桂(IC50,2.47μg/mL)、石榴(IC50,2.40μg/mL)和多花山姜(IC50,1.03μg/mL)的抑制活性较强,与阳性对照 RK-682(IC50,2.05μg/mL)相当。然后评估了肉桂和八角茴香成分对 PTP1B 的抑制活性。5'-羟基-5-羟甲基-4″,5″-亚甲二氧基-1,2,3,4-二苯并-1,3,5-环庚三烯(2;IC50,29.7μM)和反式肉桂醛(5;IC50,57.6μM)是肉桂的活性成分,而环羊毛甾烯-5-醇-8-酮(21;IC50,27.7μM)、山奈酚-3,4'-二甲醚(32;IC50,17.5μM)和(S)-6-姜辣素(33;IC50,28.1μM)是八角茴香的活性成分。这些结果表明,这些药用植物可能通过抑制 PTP1B 来治疗和/或预防 II 型糖尿病和/或肥胖症。

相似文献

1
Protein tyrosine phosphatase 1B inhibitory activity of Indonesian herbal medicines and constituents of Cinnamomum burmannii and Zingiber aromaticum.印度尼西亚草药和肉桂及姜黄成分对蛋白酪氨酸磷酸酶 1B 的抑制活性。
J Nat Med. 2013 Apr;67(2):264-70. doi: 10.1007/s11418-012-0674-7. Epub 2012 May 30.
2
Screening of Indonesian Edible Plants for Bioactive Constituents and a New Protein Tyrosine Phosphatase 1B Inhibitory Acylbenzene Derivative from Leaves of Indonesian Syzygium polyanthum.对印度尼西亚可食用植物进行生物活性成分筛选,并从印度尼西亚多花蒲桃叶片中发现一种新型蛋白酪氨酸磷酸酶1B抑制性酰基苯衍生物。
Chem Pharm Bull (Tokyo). 2020;68(9):903-906. doi: 10.1248/cpb.c20-00457.
3
Biological activity and phytochemical analysis of three Indonesian medicinal plants, Murraya koenigii, Syzygium polyanthum and Zingiber purpurea.三种印度尼西亚药用植物,即印度楝、多花蒲桃和紫姜的生物活性与植物化学分析。
J Acupunct Meridian Stud. 2011 Mar;4(1):75-9. doi: 10.1016/S2005-2901(11)60010-1.
4
Aldose reductase and protein tyrosine phosphatase 1B inhibitory active compounds from Syzygium cumini seeds.来自蒲桃种子的醛糖还原酶和蛋白酪氨酸磷酸酶1B抑制活性化合物。
Pharm Biol. 2015 Aug;53(8):1176-82. doi: 10.3109/13880209.2014.967784. Epub 2015 Apr 8.
5
Protein tyrosine phosphatase 1B (PTP1B)-inhibiting constituents from the leaves of Syzygium polyanthum.从多花山竹子叶中分离得到的蛋白酪氨酸磷酸酶 1B(PTP1B)抑制剂成分。
Planta Med. 2012 Aug;78(12):1378-81. doi: 10.1055/s-0032-1315000. Epub 2012 Jul 4.
6
Chemical Constituents and Bioactivities of Several Indonesian Plants Typically Used in Jamu.几种常用于爪哇草药的印度尼西亚植物的化学成分及生物活性
Chem Pharm Bull (Tokyo). 2018;66(5):506-518. doi: 10.1248/cpb.c17-00983.
7
Melanogenesis inhibitory activity of components from Salam leaf (Syzygium polyanthum) extract.香叶(Syzygium polyanthum)提取物成分的黑色素生成抑制活性。
J Nat Med. 2018 Mar;72(2):474-480. doi: 10.1007/s11418-018-1171-4. Epub 2018 Jan 13.
8
In vitro antifungal, anti-elastase and anti-keratinase activity of essential oils of Cinnamomum-, Syzygium- and Cymbopogon-species against Aspergillus fumigatus and Trichophyton rubrum.肉桂属、桃金娘属和香茅属精油对烟曲霉和红色毛癣菌的体外抗真菌、抗弹性蛋白酶和抗角蛋白酶活性。
Phytomedicine. 2011 Dec 15;19(1):48-55. doi: 10.1016/j.phymed.2011.07.005. Epub 2011 Sep 3.
9
CYP3A4 and CYP2D6 inhibitory activities of Indonesian medicinal plants.印度尼西亚药用植物的CYP3A4和CYP2D6抑制活性。
Phytomedicine. 2006 Jan;13(1-2):67-73. doi: 10.1016/j.phymed.2004.06.022. Epub 2005 Jun 29.
10
The Potent Inhibitors of Protein Tyrosine Phosphatase 1B from the Fruits of Melaleuca leucadendron.白千层果实中蛋白酪氨酸磷酸酶1B的强效抑制剂
Pharmacognosy Res. 2016 Mar;8(Suppl 1):S38-41. doi: 10.4103/0974-8490.178644.

引用本文的文献

1
Therapeutic effects of medicinal and food-based traditional herbal couples on type 2 diabetes mellitus based on pharmacodynamics and pharmacokinetics.基于药效学和药代动力学的药食同源传统中药药对治疗2型糖尿病的作用
Front Pharmacol. 2025 Apr 25;16:1560271. doi: 10.3389/fphar.2025.1560271. eCollection 2025.
2
Advances in pharmacological effects and mechanism of action of cinnamaldehyde.肉桂醛的药理作用及作用机制研究进展
Front Pharmacol. 2024 Jun 6;15:1365949. doi: 10.3389/fphar.2024.1365949. eCollection 2024.
3
The Effect of Therapeutic Doses of Culinary Spices in Metabolic Syndrome: A Randomized Controlled Trial.

本文引用的文献

1
Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptor-γ (PPARγ) and AMP-activated protein kinase (AMPK) pathways.肉桂醛通过调节过氧化物酶体增殖物激活受体-γ (PPARγ) 和 AMP 激活的蛋白激酶 (AMPK) 通路来防止脂肪细胞分化和脂肪生成。
J Agric Food Chem. 2011 Apr 27;59(8):3666-73. doi: 10.1021/jf104814t. Epub 2011 Mar 22.
2
Bioactivity-guided isolation of 1,2,3,4,6-Penta-O-galloyl-D-glucopyranose from Paeonia lactiflora roots as a PTP1B inhibitor.从白芍根中生物活性导向分离 1,2,3,4,6-五没食子酰基-D-葡萄糖作为 PTP1B 抑制剂。
J Nat Prod. 2010 Sep 24;73(9):1578-81. doi: 10.1021/np100258e.
3
烹饪香料治疗剂量对代谢综合征的影响:一项随机对照试验。
Nutrients. 2024 May 29;16(11):1685. doi: 10.3390/nu16111685.
4
Effect of Cinnamaldehyde on Systemic Candida albicans Infection in Mice.肉桂醛对小鼠系统性白色念珠菌感染的影响。
Chin J Integr Med. 2025 Jul;31(7):644-648. doi: 10.1007/s11655-023-3754-5. Epub 2024 Apr 27.
5
Effect of herbal extracts and Saroglitazar on high-fat diet-induced obesity, insulin resistance, dyslipidemia, and hepatic lipidome in C57BL/6J mice.草药提取物和沙罗格列他对高脂饮食诱导的C57BL/6J小鼠肥胖、胰岛素抵抗、血脂异常及肝脏脂质组的影响。
Heliyon. 2023 Nov 4;9(11):e22051. doi: 10.1016/j.heliyon.2023.e22051. eCollection 2023 Nov.
6
Efficacy of Young Cinnamomum zeylanicum Blume Bark on Hyperglycemia and PTPase Activity in Type 2 Diabetes.幼龄锡兰肉桂树皮对2型糖尿病患者高血糖及蛋白酪氨酸磷酸酶活性的影响
Cureus. 2023 Feb 15;15(2):e35023. doi: 10.7759/cureus.35023. eCollection 2023 Feb.
7
Antioxidant and antidiabetic compounds identification in several Indonesian underutilized Zingiberaceae spices using SPME-GC/MS-based volatilomics and methods.利用基于固相微萃取-气相色谱/质谱联用的挥发物组学及方法鉴定几种印度尼西亚未充分利用的姜科香料中的抗氧化和抗糖尿病化合物。
Food Chem X. 2022 Mar 16;14:100285. doi: 10.1016/j.fochx.2022.100285. eCollection 2022 Jun 30.
8
Effect of Cinnamaldehyde on C. albicans cell wall and (1,3)- β - D-glucans in vivo.肉桂醛对体内白色念珠菌细胞壁和(1,3)-β-D-葡聚糖的影响。
BMC Complement Med Ther. 2022 Jan 31;22(1):32. doi: 10.1186/s12906-021-03468-y.
9
Effects of Cinnamaldehyde on the Cell Wall of and Its Application in Treating Mice with Invasive Pulmonary Aspergillosis.肉桂醛对烟曲霉细胞壁的影响及其在侵袭性肺曲霉病小鼠治疗中的应用
Evid Based Complement Alternat Med. 2018 Oct 4;2018:5823209. doi: 10.1155/2018/5823209. eCollection 2018.
10
Effect of Cinnamaldehyde on Glucose Metabolism and Vessel Function.肉桂醛对葡萄糖代谢和血管功能的影响。
Med Sci Monit. 2017 Aug 9;23:3844-3853. doi: 10.12659/MSM.906027.
Cinnamon as a supplemental treatment for impaired glucose tolerance and type 2 diabetes.
Curr Diab Rep. 2010 Jun;10(3):170-2. doi: 10.1007/s11892-010-0106-6.
4
Insulinotropic effect of cinnamaldehyde on transcriptional regulation of pyruvate kinase, phosphoenolpyruvate carboxykinase, and GLUT4 translocation in experimental diabetic rats.肉桂醛对实验性糖尿病大鼠丙酮酸激酶、磷酸烯醇式丙酮酸羧激酶和 GLUT4 易位的转录调节的促胰岛素作用。
Chem Biol Interact. 2010 Jun 7;186(1):72-81. doi: 10.1016/j.cbi.2010.03.044. Epub 2010 Apr 2.
5
Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice.抑制 PTP1B 可恢复 IRS2 缺陷型小鼠肝脏胰岛素信号转导中的 IRS1 介导作用。
Diabetes. 2010 Mar;59(3):588-99. doi: 10.2337/db09-0796. Epub 2009 Dec 22.
6
Recent advances in the discovery of competitive protein tyrosine phosphatase 1B inhibitors for the treatment of diabetes, obesity, and cancer.用于治疗糖尿病、肥胖症和癌症的竞争性蛋白酪氨酸磷酸酶1B抑制剂的最新发现进展。
J Med Chem. 2010 Mar 25;53(6):2333-44. doi: 10.1021/jm901090b.
7
Ameliorative effect of the cinnamon oil from Cinnamomum zeylanicum upon early stage diabetic nephropathy.肉桂油(樟科樟属肉桂)对早期糖尿病肾病的改善作用。
Planta Med. 2010 Mar;76(5):412-7. doi: 10.1055/s-0029-1186237. Epub 2009 Oct 29.
8
In vitro mechanism-based inactivation of cytochrome P450 3A4 by a new constituent of Cinnamomum burmani.
Planta Med. 2008 Oct;74(12):1474-80. doi: 10.1055/s-2008-1081351.
9
Antibacterial properties and major bioactive components of cinnamon stick (Cinnamomum burmannii): activity against foodborne pathogenic bacteria.桂皮(阴香)的抗菌特性及主要生物活性成分:对食源性病原体的抗菌活性
J Agric Food Chem. 2007 Jul 11;55(14):5484-90. doi: 10.1021/jf070424d. Epub 2007 Jun 13.
10
Recent development of small molecular specific inhibitor of protein tyrosine phosphatase 1B.蛋白酪氨酸磷酸酶1B小分子特异性抑制剂的研究进展
Med Res Rev. 2007 Jul;27(4):553-73. doi: 10.1002/med.20079.